HomeTrading IdeasUS Dollar Retreats as...

US Dollar Retreats as Powell Shuts Down July Rate Cut Hopes

  • Israel-Iran truce holds; investors focus on the US economy
  • Powell shuts down July rate cut expectations
  • US equity rally pauses as dollar tries to recover
  • Oil hovers around $65, gold bounces higher

Mideast Truce Holds, Oil Struggles

As the shortened one-day NATO summit is underway today, investors are settling into the newly found ceasefire in the Middle East, overlooking violations from either side, as both the Israeli and Iranian administrations claim victory. The truce remains fragile and will most likely be tested over the next days, with the risk of a relapse being quite high.

With equity indices benefiting from the prevailing risk-on sentiment, and the already 2.5% up this week and within touching distance of the all-time high of 6,147, the oil market is desperately trying to find its footing. The double-digit increase since June 13 has swiftly evaporated, with now trading at $65, as both consumers and central banks are breathing a sigh of relief ahead of the summer.

Fed, Tariffs and Budget Bill

Notably, the safe-haven bid that boosted the for a few sessions has diminished, with the greenback on the back foot again as investors refocus on the non-geopolitical agenda. is up 0.8% this week, the ailing is gaining 1.2% against the dollar, and touched 145. Japan’s stronger services report and the slightly more hawkish mini-minutes from the June BoJ meeting have failed to support the yen.

While Trump appears to control developments on the foreign policy arena, he is unlikely to be content with the considerable lack of progress on key issues such as monetary policy, the budget bill, and tariffs.

Fed Chair Powell will deliver his testimony to the Senate Banking Committee today, with the message being identical to Tuesday’s appearance before the House Financial Services Committee. A solid US economy is allowing the FOMC to maintain its current monetary stance while waiting for further information about the budget bill and tariffs.

While Powell kept that door open to during 2025, given that most policymakers are open to such an action, he shut the door to a July rate cut, as put forward by Fed Governors Waller and Bowman in recent days. However, Powell acknowledged that if inflation fails to accelerate aggressively, rate cuts could come sooner. Markets are currently fully pricing in a 25bps rate cut in September and a total of 60bps of easing during 2025.

Asked about the expected timing of the impact of tariffs, Powell responded that a meaningful inflation effect could be seen from June onwards, thus increasing the focus on the next and reports. If this proves to be the case and inflation accelerates over the summer, FOMC members will feel vindicated for having resisted pressure from the US administration to cut rates.Economic Calendar

Deadlines Loom, Newsflow to Pick Up

With the July 4 deadline set by Republicans fast approaching, the Senate plans a vote of the US budget bill on Friday. At this stage, the outcome is unclear, with a likely failure forcing Senators and the US administration back to the negotiating table. A short delay for further negotiations is possible, potentially even necessary, for an agreement, further denting the current weak attractiveness of the dollar.

Speaking of deadlines, the 90-day pause on reciprocal tariffs will end on July 9, just two weeks away, with sources close to the US administration paving the way for a number of trade deals being announced soon. White House Adviser Hassett concurred by stating that “we will see a sequence of trade deals around the 4th of July. The administration has been focused on getting the One Big Beautiful Bill passed through Congress”.

While US officials continue to negotiate with Japan, South Korea, Vietnam and the EU, investors view another extension as almost certain. However, Trump might first choose to employ this familiar guidebook, threatening the affected countries with triple-digit tariffs, which could potentially unsettle risk markets once again.

Most Popular

More from Author

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on...

Read Now

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody, for moderate-to-severe...